OHG Brands Announces Leadership Team

ASHA Responds to New Speech-Language Pathology Treatment Codes in 2027 Medicare Physician Fee Schedule

NetClass Technology Inc Announces Pricing of $1.2 Million Registered Direct Offering

ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law

Huntress Unleashes Wave of Agentic Security Platform Innovations to Beat Adversaries at Machine Speed

DRAFT Media Partners Declines Acquisition Offer

Duolingo, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DUOL

UNCF Empower Me Tour Continues in Milwaukee, WI, on Nov. 10th with College Readiness Conference, Offering Scholarships and On-Site College...

Bank of America Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BAC

O-I Glass, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - OI

D-Wave Quantum Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QBTS

What Should Yiren Digital Ltd. Investors Know After 44.05% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class...

QBTS Investors Have Opportunity to Lead D-Wave Quantum Inc. Securities Fraud Lawsuit with SBS Law

FirstService Residential selected for Sarasota's historic Mira Mar redevelopment

Parabolic Technologies, Inc. Announces Closing of $13.5 Million Underwritten Public Offering

What Should Compass, Inc. Investors Know After 28% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead...

Kaplan Fox & Kilsheimer LLP Encourages Investors of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) to Contact the Firm Regarding...

What Should Netcapital Inc. Investors Know After 28.62% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action...

Canada's Indigenous Investment Leaders to Gather in Toronto as First Nations Investment Forum Unveils 2026 Program

Skyhawk Therapeutics Announces First U.S. Patients Dosed in Pivotal FALCON-HD Study Evaluating SKY-0515 in Huntington's Disease